TFX · NYSE · Medical - Instruments & Supplies

Teleflex (TFX)

Builds medical devices for vascular access, interventional, and surgical procedures.

$125.05
vs last close+0.25 (+0.20%)

In millions of USD, except per-share figures

In millionsQ3 FY23Oct 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue746774738750764795701781913569548570
Cost of revenue330342322333334355311350461262241239
Gross profit416431416416430440389431452307307332
251349421300281550264276481271287271
Research & development383637413945363957494445
213261243251247255223215282222226214
Selling & marketing00−138000000000
General & administrative0038100000000214
Other expenses0521418−525152214201713
Operating income16582−5117149−110126155−30362060
−16−22−21−19−19−16−17−20−409−49−24−15
Interest income732222222221
Interest expense232623212119192238282628
Other non-operating income−7−3−2−2−2−2−2−23712148−13
Income before tax15060−2697131−127109135−439−12−445
Income tax expense1229−421720101413−30−913
Net income from continuing operations138311680111−13795123−409−4−542
Discontinued operations−100000000−711−360
Net income137311580111−13795123−409−714−8102
EPS, basic$2.92$0.66$0.32$1.70$2.38−$2.95$2.08$2.77−$9.24−$16.15−$0.18$2.29
EPS, diluted$2.90$0.66$0.32$1.69$2.36−$2.95$2.07$2.77−$9.24−$16.15−$0.18$2.28
Weighted average shares, basic474747474746464644444444
Weighted average shares, diluted474747474746464644444444
EBITDA23015063187220−36195223−32316−473
Depreciation & amortization5864666869726766780240
EBIT17386−3119152−108127157−40116−2873